Tombot is making highly realistic robotic animals designed to stimulate the formation of emotional attachment and relieve the behavioral and psychological symptoms of dementia. Tombot aims to be the first affordable, FDA-regulated robotic animal.

Security Type
Min Investment
Santa Clarita, CA
Min Raise
Offering Date
May 03, 2021
Max Raise
Expected Close Date
November 03, 2021
Amount Raised
Deal Notes

Price per share $1.55

Use of Proceeds

The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Vendor payments. Salary payments made to one’s self, a friend or relative. Any expense labeled “Travel and Entertainment”.


Thomas Edward Stevens, Chairman - Board of Directors
Tom has been in the high tech industry since 1985 - the early days of the PC revolution. The extraordinary demand for PCs at the time far outstripped the supply of workers, creating unusual opportunities for anyone involved.

Henry P. Schorz, Chief Technical Officer
Hank has been a Chief-level executive for more than 40 years. As an engineering and operations expert, Hank has built multiple companies into industry leaders. Hank has also spent many years as a hobbyist roboticist and remote-control airplane builder and competitor.

Jesse M. Schorz, Chief Operating Officer
Jesse has spent 20 years in management and leadership positions. Jesse built and managed high-performing internal engineering and operations teams - the largest operating divisions at ACT.

Deal Perks

  • $249 | Tier I Priority Waitlist (after Kickstarter & Front of the Line Passes)
  • $1,000 | Tier II Front of the Waitlist Line Pass.
  • $2,500 | Tier III Front of the Waitlist Line Pass + Exclusive Annual Investor Call & Q&A.
  • $5,000 | Tier IV Front of the Waitlist Line Pass + Exclusive Semi-Annual Major Annual Investor Call & Q&A.
  • $10,000 | Tier V Front of the Waitlist Line + Exclusive Semi-Annual Major Investor Call & Q&A + Dinner and Private Tour of Tombot Robotics Lab + Invitations to Tombot Major Investor Events.

Research Reports

No reports have been submitted

Become a Reporter

Security Description

Key Deal Facts

Named one of TIME Magazine’s 2020 Best Inventions, Tombot’s realistic robot animals were designed to help 50M+ seniors with dementia and mild cognitive impairment worldwide. A number projected to reach 152M+ by 2050.
Tombot conducted three rounds of consumer studies with 100s of seniors with dementia during product design, and we believe Tombot will be the first realistic and affordable, FDA-regulated robotic animal.
$3M+ in commitments from institutional and accredited angel investors, with 7,500+ pre-order and waitlist customers.